Daily Media Digest August 26, 2021

COVID-19 breakthrough cases signal next phase of Canada’s battle – The Globe and Mail
The Globe and Mail
“In her lab at Mount Sinai Hospital in Toronto, Dr. Gingras is culturing cells that have been engineered to glow when they are infected with the coronavirus. The …”
TAGS: COVID-19, pandemic, breakthrough cases, Lunenfeld-Tannenbaum RI

3 key factors in how Canada will fare during the 4th wave of COVID-19
“Multiple experts told CBC News that there are a few key factors in how the pandemic will play out as the delta variant continues spreading.”
TAGS: COVID-19, pandemic, public health, delta variant, McMaster University, VIDO Inter-Vac, University of Saskatchewan

Emergency doctors stepped up beyond the hospital during pandemic
Hamilton Health Sciences
“Throughout the pandemic, many HHS emergency doctors supported initiatives in the community in addition to working in the hospital.”
TAGS: COVID-19, pandemic, emergency medicine, community health, Hamilton Health Sciences

With a focus on skin cells, U of T’s Michael Sefton seeks ‘huge step forward’ in diabetes treatment
University of Toronto
“Michael Sefton, a renowned University of Toronto tissue engineer, is confident enough about the possibility that – with support from the type 1 diabetes non-profit JDRF – he is about to launch a major new chapter in his research.”
TAGS: diabetes, chronic illness, skin cells, innovative treatment, JDRF

Honouring and inspiring a new generation of health leaders and innovators
Canadian Medical Hall of Fame
“The Canadian Medical Hall of Fame partners with donors, MD Financial Management Inc. (MD) and Canada’s medical schools to recognize young leaders who exemplify qualities of CMHF Laureates: perseverance, collaboration and an entrepreneurial spirit.”
TAGS: health leaders, award, medical school, Canadian Medical Hall of Fame

Chemotherapy concept pioneered at Sunnybrook Research Institute highlighted in The Lancet
Sunnybrook Research Institute
“Sunnybrook Research Institute Senior Scientist Dr. Robert Kerbel shares insight on progress made in the field of metronomic chemotherapy in an invited editorial commentary “Adjuvant metronomic chemotherapy for locoregionally advanced nasopharyngeal carcinoma,” recently published in The Lancet.”
TAGS: cancer, cancer research, chemotherapy, Sunnybrook RI